ArticleACS pharmacology & translational science2026

Lentiviral-Mediated Expression of a Novel Transforming Growth Factor‑β (TGF-β) Inhibitor Peptibody Therapeutically Mitigates Established Liver Fibrosis by Modulating Inflammation and Inducing Metabolic Reprogramming.

Anabela La Colla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.